Rajiv Kaul
Portfolio Manager
Description:
Rajiv Kaul is a portfolio manager and research analyst for Fidelity Investments. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing and other financial products and services to more than 20 million individuals, institutions and financial intermediaries. Mr. Kaul manages Fidelity Select Biotechnology Portfolio and Fidelity Advisor Biotechnology Fund. Mr. Kaul has spent 20 years at Fidelity. During this period, Mr. Kaul has been widely recognized for his leadership within the biotech industry by media outlets such as the Wall Street Journal, New York Times, Bloomberg, CNBC, USA Today, and Barrons to name a few. He is often ranked among the top rated healthcare investors in the US. In 2013, 2014 and 2015 Mr. Kaul was the winner of the Lipper Award for best 3 yr risk-adjusted performance within the Biotechnology and Healthcare industry, adding to this the Best Fund over 5 years Lipper Fund Award for 2015. Mr. Kaul is a member of the Research Advisory Council at Massachusetts General Hospital (MGH). MGH is the teaching hospital for Harvard Medical School and is rated the No. 1 hospital in America by US News & World Report. He is a graduate of Harvard University and worked at McKinsey & Company prior to joining Fidelity
Summary:
Rajiv Kaul is a portfolio manager and research analyst for Fidelity Investments. Fidelity Investments is a leading provider of investment ma...
Number of Registered Investments:1
Contact Details:
- Find the location here
- No email is provided
Find more here
Email is Not Provided
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.
English 
Polish 